Fortress Biotech (FBIO)
(Delayed Data from NSDQ)
$2.25 USD
-0.35 (-13.46%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $2.25 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/12/24 |
---|---|
Current Quarter | -1.32 |
EPS Last Quarter | -1.03 |
Last EPS Surprise | 49.26% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -5.07 |
Next Year | -3.36 |
EPS (TTM) | -6.10 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 14.97M | 28.21M | 81.22M | 130.42M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 15.90M | 39.61M | 86.53M | 134.33M |
Low Estimate | 14.04M | 16.80M | 75.90M | 126.50M |
Year ago Sales | 17.39M | 34.75M | 84.51M | 81.22M |
Year over Year Growth Est. | -13.92% | -18.83% | -3.90% | 60.58% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.32 | -1.36 | -5.07 | -3.36 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -1.75 | -2.15 | -6.86 | -4.16 |
High Estimate | -0.88 | -0.56 | -3.27 | -2.56 |
Low Estimate | -1.75 | -2.15 | -6.86 | -4.16 |
Year ago EPS | -3.60 | -0.94 | -8.47 | -5.07 |
Year over Year Growth Est. | 63.33% | -44.68% | 40.14% | 33.63% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.32 | -1.36 | -5.07 | -3.36 |
7 Days Ago | -1.32 | -1.36 | -5.07 | -3.36 |
30 Days Ago | -1.32 | -1.36 | -5.07 | -3.36 |
60 Days Ago | -1.32 | -1.36 | -5.07 | -3.36 |
90 Days Ago | -1.83 | -1.51 | -6.58 | -5.58 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.32 | -1.36 | -5.07 | -3.36 |
Zacks Consensus Estimate | -1.32 | -1.36 | -5.07 | -3.36 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.03 | -0.53 | -0.94 | -3.60 | NA |
Estimate | -2.03 | NA | -3.53 | -3.90 | NA |
Difference | 1.00 | NA | 2.59 | 0.30 | 1.30 |
Surprise | 49.26% | NA | 73.37% | 7.69% | 43.44% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more